‘We are in the era of treatment’: New Alzheimer’s report shows numbers are increasing, but so are treatment options Post author:Randy Banks Post published:April 24, 2023 Post category:News There are now two FDA-approved drugs for Alzheimer’s, however neither are covered by Medicare and Medicaid. Full Story You Might Also Like Insight into caring for patients with dementia in West Herts April 1, 2025 How Is Alzheimer’s Disease Diagnosed? April 5, 2023 Bone marrow myelopoiesis dysfunction in Alzheimer’s disease limits monocyte homing to the brain and drives disease progression September 9, 2026
Bone marrow myelopoiesis dysfunction in Alzheimer’s disease limits monocyte homing to the brain and drives disease progression September 9, 2026